Physician profile
David W Munter
NPI 1073545232
$762.97
in general payments reported to CMS, 2019-2025
10 companies · $138 in 2025
The $138 reported for 2025 was more than what a typical Emergency Medicine provider received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $333 · 2020: $51.31 · 2023: $157 · 2024: $84.03 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $379.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $378.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $225.74 | 2019-2023 | Collagenase Santyl, Allevyn Heel 10.5cm X 13.5cm Ctn 5, Iodosorb Ointment 40g USA |
| Mimedx Group, INC. | $132.49 | 2025 | |
| Kci USA, INC. | $107.90 | 2019 | |
| Abbvie INC. | $97.28 | 2019 | |
| Kerecis Limited | $55.33 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Misonix INC | $35.08 | 2020 | |
| Lifenet Health | $34.02 | 2024-2025 | Theragenesis Wound Matrix |
| Alexion Pharmaceuticals, INC. | $30.56 | 2023 | |
| Organogenesis INC. | $29.08 | 2019-2020 | |
| Orexo US, INC. | $15.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Munter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.